Clinical management of secondary angiosarcoma after breast conservation therapy.
Identifieur interne : 001616 ( PubMed/Checkpoint ); précédent : 001615; suivant : 001617Clinical management of secondary angiosarcoma after breast conservation therapy.
Auteurs : Martina Zemanova [Slovaquie] ; Katarina Machalekova [Slovaquie] ; Monika Sandorova [Slovaquie] ; Elena Boljesikova [Slovaquie] ; Marta Skultetyova [Slovaquie] ; Juraj Svec [Slovaquie] ; Andrej Zeman [Autriche]Source :
- Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [ 1507-1367 ] ; 2014.
Abstract
The aim of this paper is to summarize the treatment outputs of secondary angiosarcoma after breast conservation therapy at St. Eizabeth Cancer Centre, Slovakia.
DOI: 10.1016/j.rpor.2013.07.013
PubMed: 24936318
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24936318Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical management of secondary angiosarcoma after breast conservation therapy.</title><author><name sortKey="Zemanova, Martina" sort="Zemanova, Martina" uniqKey="Zemanova M" first="Martina" last="Zemanova">Martina Zemanova</name><affiliation wicri:level="1"><nlm:affiliation>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia ; Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia ; Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Machalekova, Katarina" sort="Machalekova, Katarina" uniqKey="Machalekova K" first="Katarina" last="Machalekova">Katarina Machalekova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Pathology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Sandorova, Monika" sort="Sandorova, Monika" uniqKey="Sandorova M" first="Monika" last="Sandorova">Monika Sandorova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Boljesikova, Elena" sort="Boljesikova, Elena" uniqKey="Boljesikova E" first="Elena" last="Boljesikova">Elena Boljesikova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Skultetyova, Marta" sort="Skultetyova, Marta" uniqKey="Skultetyova M" first="Marta" last="Skultetyova">Marta Skultetyova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Clinical Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Svec, Juraj" sort="Svec, Juraj" uniqKey="Svec J" first="Juraj" last="Svec">Juraj Svec</name><affiliation wicri:level="1"><nlm:affiliation>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Zeman, Andrej" sort="Zeman, Andrej" uniqKey="Zeman A" first="Andrej" last="Zeman">Andrej Zeman</name><affiliation wicri:level="3"><nlm:affiliation>Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24936318</idno><idno type="pmid">24936318</idno><idno type="doi">10.1016/j.rpor.2013.07.013</idno><idno type="wicri:Area/PubMed/Corpus">001485</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001485</idno><idno type="wicri:Area/PubMed/Curation">001485</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001485</idno><idno type="wicri:Area/PubMed/Checkpoint">001485</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001485</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical management of secondary angiosarcoma after breast conservation therapy.</title><author><name sortKey="Zemanova, Martina" sort="Zemanova, Martina" uniqKey="Zemanova M" first="Martina" last="Zemanova">Martina Zemanova</name><affiliation wicri:level="1"><nlm:affiliation>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia ; Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia ; Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Machalekova, Katarina" sort="Machalekova, Katarina" uniqKey="Machalekova K" first="Katarina" last="Machalekova">Katarina Machalekova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Pathology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Sandorova, Monika" sort="Sandorova, Monika" uniqKey="Sandorova M" first="Monika" last="Sandorova">Monika Sandorova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Boljesikova, Elena" sort="Boljesikova, Elena" uniqKey="Boljesikova E" first="Elena" last="Boljesikova">Elena Boljesikova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Skultetyova, Marta" sort="Skultetyova, Marta" uniqKey="Skultetyova M" first="Marta" last="Skultetyova">Marta Skultetyova</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>Department of Clinical Oncology, St. Elizabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Svec, Juraj" sort="Svec, Juraj" uniqKey="Svec J" first="Juraj" last="Svec">Juraj Svec</name><affiliation wicri:level="1"><nlm:affiliation>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia.</nlm:affiliation><country xml:lang="fr">Slovaquie</country><wicri:regionArea>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava</wicri:regionArea><wicri:noRegion>Bratislava</wicri:noRegion></affiliation></author><author><name sortKey="Zeman, Andrej" sort="Zeman, Andrej" uniqKey="Zeman A" first="Andrej" last="Zeman">Andrej Zeman</name><affiliation wicri:level="3"><nlm:affiliation>Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author></analytic><series><title level="j">Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology</title><idno type="ISSN">1507-1367</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this paper is to summarize the treatment outputs of secondary angiosarcoma after breast conservation therapy at St. Eizabeth Cancer Centre, Slovakia.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24936318</PMID><DateCreated><Year>2014</Year><Month>06</Month><Day>17</Day></DateCreated><DateCompleted><Year>2014</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1507-1367</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology</Title><ISOAbbreviation>Rep Pract Oncol Radiother</ISOAbbreviation></Journal><ArticleTitle>Clinical management of secondary angiosarcoma after breast conservation therapy.</ArticleTitle><Pagination><MedlinePgn>37-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rpor.2013.07.013</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">The aim of this paper is to summarize the treatment outputs of secondary angiosarcoma after breast conservation therapy at St. Eizabeth Cancer Centre, Slovakia.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Angiosarcoma of the breast is a rare but very aggressive malignant tumor of the vascular endothelium, characterized by rapidly proliferating and extensively infiltrating growth. Breast angiosarcoma may occur de novo, or as a complication of radiation therapy, or chronic lymphedema secondary to axillary lymph node dissection for mammary carcinoma. Radiotherapy in the treatment of breast cancer is associated with an increased risk of subsequent sarcoma.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Retrospective study of medical records from the cancer databases was done in order to analyze the secondary breast angiosarcoma. This disease is an iatrogenic condition that warrants close follow-up and judicial use of radiotherapy in breast conserving therapy. Therefore, it is more prevalent in cases treated with radiotherapy, occurring especially in or adjacent to the radiation field. Clinical histories and follow-up data of identified patients after breast conservation therapy of invasive breast cancer were reviewed. In addition, a comprehensive literature review on diagnosis and treatment procedures was done in order to summarize state-of-the-art clinical approach.</AbstractText><AbstractText Label="RESULTS AND DISCUSSIONS" NlmCategory="CONCLUSIONS">Three cases of secondary angiosarcoma after breast conservation therapy (BCT) were identified among 4600 patients treated at St. Elizabeth Cancer Institute during previous 16 years (1995-2011). Secondary breast angiosarcoma was diagnosed in a median period of 11 years following primary radiotherapy, median age at the time of diagnosis was 75 years. Surgical treatment consisted of radical mastectomy. The first patient, a 56-year-old woman received neoadjuvant chemotherapy (docetaxel + gemcitabin), second one (75 year) was treated by radiotherapy (TD 26 Gy, 2 Gy per fraction), since chemotherapy was not indicated. The last patient (80 year) got adjuvant chemotherapy (paclitaxel). Average follow up of the patients was 31 months. As of 31 July 2012, our patients were doing well without evidence of recurrent disease after treatment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Angiosarcoma remains a difficult management problem with poor loco-regional and distal control. In our study, an overall incidence rate of secondary breast angiosarcoma is 0.065%. Although the prognosis for this disease is poor (typical survival period is 14.5-34 months with a 5-year survival rate of approximately 15%), all the three patients treated at our institute are alive and disease-free at the end of reported period. Finally, it is assumed that the use of breast conserving therapy will increase the incidence of post-irradiation angiosarcoma but the small difference in risk of subsequent sarcoma of the breast cancer patients receiving radiotherapy does not suppress its benefit.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zemanova</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia ; Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machalekova</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandorova</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boljesikova</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skultetyova</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Oncology, St. Elizabeth Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svec</LastName><ForeName>Juraj</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1st Department of Oncology, Faculty of Medicine, Comenius University and St. Elisabeth Cancer Institute, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeman</LastName><ForeName>Andrej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Rep Pract Oncol Radiother</MedlineTA><NlmUniqueID>100885761</NlmUniqueID><ISSNLinking>1507-1367</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jul 1;27(19):3133-40</RefSource><PMID Version="1">19451436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Clin Pract Oncol. 2008 Dec;5(12):727-36</RefSource><PMID Version="1">18936792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 2004 Jun;28(6):781-8</RefSource><PMID Version="1">15166670</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2003 Aug 1;9(8):2926-32</RefSource><PMID Version="1">12912938</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Jul 1;92(1):172-80</RefSource><PMID Version="1">11443624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Oncol Rep. 2002 Nov;4(6):515-9</RefSource><PMID Version="1">12354365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2007 Apr;18(4):619-21</RefSource><PMID Version="1">17351257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Jul 1;25(19):2755-63</RefSource><PMID Version="1">17602081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2004 Jun;239(6):903-9; discussion 909-10</RefSource><PMID Version="1">15166970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer J. 2005 May-Jun;11(3):241-7</RefSource><PMID Version="1">16053668</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1981 Oct 15;48(8):1907-21</RefSource><PMID Version="1">7197190</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2006 Feb;15(1):117-8</RefSource><PMID Version="1">16473744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jul 1;27(19):3154-60</RefSource><PMID Version="1">19451429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2011 Jun;20(3):199-204</RefSource><PMID Version="1">21398126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer. 2007;14(2):245-9</RefSource><PMID Version="1">17485913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2007 Dec;18(12):2030-6</RefSource><PMID Version="1">17974557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2007 May 1;109(9):1863-9</RefSource><PMID Version="1">17385194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2003 Oct;186(4):359-61</RefSource><PMID Version="1">14553850</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2003 Apr 15;97(8):1832-40</RefSource><PMID Version="1">12673708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2005 Mar-Apr;11(2):115-23</RefSource><PMID Version="1">15730457</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2002 Oct 17;347(16):1233-41</RefSource><PMID Version="1">12393820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1948 May;1(1):64-81</RefSource><PMID Version="1">18867440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2012 Feb;23(2):501-8</RefSource><PMID Version="1">21464156</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2010 Aug;122(3):619-26</RefSource><PMID Version="1">20480227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg Pathol. 1981 Oct;5(7):629-42</RefSource><PMID Version="1">7199829</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):620-6</RefSource><PMID Version="1">11849782</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Apr 15;116(8):1872-8</RefSource><PMID Version="1">20162708</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2004 Sep 2;351(10):971-7</RefSource><PMID Version="1">15342805</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Dec;94(3):195-8</RefSource><PMID Version="1">16258704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2009;48(7):1078-9</RefSource><PMID Version="1">19235566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Pathol. 1994 Dec;102(6):757-63</RefSource><PMID Version="1">7801888</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2008 Nov;44(16):2433-6</RefSource><PMID Version="1">18771914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):113-9</RefSource><PMID Version="1">10219803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2012 Aug;21(4):584-9</RefSource><PMID Version="1">22305554</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2010 Oct;11(10):983-91</RefSource><PMID Version="1">20537949</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2005 Dec 15;104(12):2682-8</RefSource><PMID Version="1">16288486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Plast Reconstr Aesthet Surg. 2011 Aug;64(8):1036-42</RefSource><PMID Version="1">21377947</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Mar 1;25(7):900-1</RefSource><PMID Version="1">17327613</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2005 Nov-Dec;11(6):517-8</RefSource><PMID Version="1">16297124</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2005 Jul 15;104(2):361-6</RefSource><PMID Version="1">15948172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1971 Nov;28(5):1087-99</RefSource><PMID Version="1">5288429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Histopathology. 2006 Jan;48(1):106-14</RefSource><PMID Version="1">16359542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Diagn Pathol. 2009 Jun;13(3):147-50</RefSource><PMID Version="1">19433291</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1948 May;1(1):3-29</RefSource><PMID Version="1">18867438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2001 Mar;76(3):239-41</RefSource><PMID Version="1">11276029</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Nov 10;26(32):5269-74</RefSource><PMID Version="1">18809609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Oncol. 2010 May;21 Suppl 5:v198-203</RefSource><PMID Version="1">20555081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiology. 1992 Jun;183(3):649-54</RefSource><PMID Version="1">1584913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2004 Nov;30(9):982-6</RefSource><PMID Version="1">15498645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1995 Jun 15;75(12):2867-74</RefSource><PMID Version="1">7773935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Jun 15;20(12):2824-31</RefSource><PMID Version="1">12065559</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC4056516</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">External-beam radiotherapy</Keyword><Keyword MajorTopicYN="N">Multimodality therapy</Keyword><Keyword MajorTopicYN="N">Radiationinduced late effects</Keyword><Keyword MajorTopicYN="N">Sarcoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>09</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>04</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>07</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24936318</ArticleId><ArticleId IdType="doi">10.1016/j.rpor.2013.07.013</ArticleId><ArticleId IdType="pii">S1507-1367(13)01018-3</ArticleId><ArticleId IdType="pmc">PMC4056516</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Autriche</li><li>Slovaquie</li></country><region><li>Vienne (Autriche)</li></region><settlement><li>Vienne (Autriche)</li></settlement></list><tree><country name="Slovaquie"><noRegion><name sortKey="Zemanova, Martina" sort="Zemanova, Martina" uniqKey="Zemanova M" first="Martina" last="Zemanova">Martina Zemanova</name></noRegion><name sortKey="Boljesikova, Elena" sort="Boljesikova, Elena" uniqKey="Boljesikova E" first="Elena" last="Boljesikova">Elena Boljesikova</name><name sortKey="Machalekova, Katarina" sort="Machalekova, Katarina" uniqKey="Machalekova K" first="Katarina" last="Machalekova">Katarina Machalekova</name><name sortKey="Sandorova, Monika" sort="Sandorova, Monika" uniqKey="Sandorova M" first="Monika" last="Sandorova">Monika Sandorova</name><name sortKey="Skultetyova, Marta" sort="Skultetyova, Marta" uniqKey="Skultetyova M" first="Marta" last="Skultetyova">Marta Skultetyova</name><name sortKey="Svec, Juraj" sort="Svec, Juraj" uniqKey="Svec J" first="Juraj" last="Svec">Juraj Svec</name></country><country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Zeman, Andrej" sort="Zeman, Andrej" uniqKey="Zeman A" first="Andrej" last="Zeman">Andrej Zeman</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001616 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001616 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24936318
|texte= Clinical management of secondary angiosarcoma after breast conservation therapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24936318" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |